• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Covidien

Covidien

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Research and Markets: The Medical Device Market: France

    Research and Markets: The Medical Device Market: France

  2. Research and Markets: Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market

    Research and Markets: Global Medical Devices Market 2012-2020: Market Size, Share, Trends, Analysis and Forecasts for the $289 Billion Market

  3. Research and Markets: European Soft Tissue Reinforcement and Regeneration (Allografts, Xenografts, and Alloplasts) Markets for 2015

    Research and Markets: European Soft Tissue Reinforcement and Regeneration (Allografts, Xenografts, and Alloplasts) Markets for 2015

  4. 'Smart money' cools on Alibaba, other themes from hedge-fund portfolios

    'Smart money' cools on Alibaba, other themes from hedge-fund portfolios

  5. Research and Markets: Global Hernia Repair Devices and Consumables Market 2013-2020 - Analysis and Forecasts for the 3.9 Billion Market

    Research and Markets: Global Hernia Repair Devices and Consumables Market 2013-2020 - Analysis and Forecasts for the 3.9 Billion Market

  6. Research and Markets: Dialysis Catheters Market in the US 2015-2019: The Usage of Alternative Treatment Options for Vascular Access Hinders Market Growth

    Research and Markets: Dialysis Catheters Market in the US 2015-2019: The Usage of Alternative Treatment Options for Vascular Access Hinders Market Growth

  7. Research and Markets: The Urinary Incontinence Products Market in the US to Grow at a CAGR of 4.1% over the Period 2014-2019

    Research and Markets: The Urinary Incontinence Products Market in the US to Grow at a CAGR of 4.1% over the Period 2014-2019

  8. The Reluctant Bulls of 2014

    After a few fits and starts, Tyco is now set to trade under three separate tickers starting July 2. Tyco International will retain the TYC ticker, Tyco Electronics will assume the TEL ticker, and Covidien , the health-care concern, will trade as COV . We'll have a separate analyst covering each; ...

  9. Covidien's Wide-Moat Device Business Positioned Well for Long-Term Growth

    R&D investments and a narrowed focus have widened the firm's competitive advantages.

  10. Covidien's Mallinckrodt Spin-Off Faces Challenging Environment

    Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.